Glovax to start P7.5bn vaccine plant operations in October 2022
The Department of Trade and Industry (DTI) and Glovax Biotech Corp. signed a memorandum of agreement with the Department of Trade and Industry (DTI) regarding the P7.5 billion-COVID-19 vaccine plant project in the country.
Glovax is looking to start the facility operations in October 2022. It will fill vials with COVID-19 vaccines developed by its South Korean technology partner EuBiologics Co. Ltd.
The Anti-Red Tape Authority, Department of Health, Food and Drug Administration, Department of Trade and Industry-Board of Investments, Department of Science and Technology, and National Task Force Against COVID-19 has recently signed a joint memorandum circular providing a green lane for COVID-19 manufacturers in the country.
United Laboratories Inc., IG/IP Biotech and Dr. Zen Biotech has previously expressed interest in putting up vaccine manufacturing plants in the country.
